cdy annc:
Sydney, 4 March 2010: Cellmid (ASX:CDY) today signed research, development and collaboration agreements with Pharmahungary for the pre-clinical and early clinical validation programs for midkine to treat heart attack (acute myocardial infarction or AMI).
Well that's a relieve if u bought at high
n feel some acute myocardial infarction
Here's a better release:
KayaRaya inc annc validation programs for
heart attack prevention:
*5 veg n 2 fruits
*Exercise
*DYOR
LOL
K R
No Pain No Gain bumper sticker issuer.
- Forums
- ASX - Day Trading
- daytrades march 3 morning ...
daytrades march 3 morning ..., page-11
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)